One Scientist Survives Reorganization

File Photo Breaking into an industry research job may seem like breaking through the blood-brain barrier: You can't find out about every job on the company's web site, and when the job is listed in the classified ads, the firm gets flooded with applicants. It can be tough even if you already work in industry. For a time, it seemed to Dalai Yan, a microbiologist and antibiotic researcher with Cumbre, a small biotech in Dallas, that fate would keep him from doing the research he cared about. Be

Written byKaren Young Kreeger
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Breaking into an industry research job may seem like breaking through the blood-brain barrier: You can't find out about every job on the company's web site, and when the job is listed in the classified ads, the firm gets flooded with applicants.

It can be tough even if you already work in industry. For a time, it seemed to Dalai Yan, a microbiologist and antibiotic researcher with Cumbre, a small biotech in Dallas, that fate would keep him from doing the research he cared about. Before joining Cumbre, he was a senior scientist at Eli Lilly and Co. in Indianapolis. During a recent round of layoffs at Lilly, he was asked to switch from a research position to a nonresearch department such as development. But he didn't give up on his quest for a position that allowed him to do science.

Yan looked internally and in the Indianapolis area, but ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies